A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
← catalyst calendarNCT06937931 · readout in 219 d
Sponsored by Ipsen (industry) · IPN.PA — their whole pipeline →.
Phase
Phase 2
Status
Recruiting
Study type
Interventional
Design
Randomized · Quadruple · Treatment
Enrollment
132estimated
Sites
44
Countries
Czechia, France, Germany +5
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-06-30 | actual | When the study began enrolling |
| Primary completion | 2027-03-26 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2027-11-05 | estimated | The whole study's end, after follow-up |
| First posted | 2025-04-22 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-28 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Cervical Dystonia
Interventions
- Biological: Corabotase — also filed as IPN10200
- Other: Placebo
Primary outcome
what the primary-completion date above is the date OFChange from Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total score
measured At Week 4
Permalink · IPN.PA's whole pipeline · Catalyst calendar · Every registered study · What changed